Predicted protein targets (top 6)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | LMNA | P02545 | 1/20 | 0.53 |
| ▸ | MEN1 | O00255 | 1/20 | 0.32 |
| ▸ | CYP3A4 | P08684 | 1/20 | 0.32 |
| ▸ | ALOX15 | P16050 | 1/20 | 0.32 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.32 |
| ▸ | BLM | P54132 | 1/20 | 0.32 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL3267924 | 0.97 | LMNA (0.50) | LMNAMEN1CYP3A4ALOX15KMT2A | |
| SCHEMBL3883339 | 0.97 | LMNA (0.50) | LMNAMEN1CYP3A4ALOX15KMT2A | |
| SCHEMBL11720335 | 0.97 | LMNA (0.50) | LMNAMEN1CYP3A4ALOX15KMT2A | |
| SCHEMBL29183000 | 0.97 | LMNA (0.50) | LMNAMEN1CYP3A4ALOX15KMT2A | |
| SCHEMBL20335504 | 0.97 | LMNA (0.50) | LMNAMEN1CYP3A4ALOX15KMT2A | |
| SCHEMBL28419560 | 0.97 | LMNA (0.50) | LMNAMEN1CYP3A4ALOX15KMT2A | |
| SCHEMBL28851724 | 0.94 | LMNA (0.48) | LMNAMEN1CYP3A4ALOX15KMT2A | |
| SCHEMBL9122712 | 0.93 | — | — | |
| SCHEMBL446676 | 0.93 | — | — | |
| SCHEMBL5985454 | 0.89 | LMNA (0.37) | LMNA |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 134 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-117986215-A | 2-Phenyl-4-acyl benzofurans, preparation and application thereof | 中国医学科学院药物研究所 | 2024-05-07 | — | — | CN | claimed |
| CN-117897439-A | Method for screening solvent for extraction of polyvinyl chloride, method for recovering waste material, and recovered polyvinyl chloride and composition | 株式会社LG化学 | 2024-04-16 | — | — | CN | claimed |
| US-20120220793-A1 | Method for Producing (Hydroxymethyl)Polysiloxanes | WACKER CHEMIE AG (DE) | 2012-08-30 | — | — | US | claimed |
| CN-111569086-B | Methylene carbamate linkers for use with target-drug conjugates | 西雅图基因公司 | 2024-06-21 | — | — | CN | disclosed |
| CN-111558049-B | Methylene carbamate linkers for use with target-drug conjugates | 西雅图基因公司 | 2024-06-21 | — | — | CN | disclosed |
| CN-117986215-A | 2-Phenyl-4-acyl benzofurans, preparation and application thereof | 中国医学科学院药物研究所 | 2024-05-07 | — | — | CN | disclosed |
| WO-2023182221-A1 | METHOD FOR PRODUCING QUANTUM DOTS | 日本化学工業株式会社 | 2023-09-28 | — | — | WO | disclosed |
| US-20230295813-A1 | AMMONIA PRODUCTION METHOD AND AMMONIA PRODUCTION APPARATUS | NISSAN CHEMICAL CORPORATION (JP) | 2023-09-21 | — | — | US | disclosed |
| US-20230295818-A1 | AMMONIA PRODUCTION METHOD AND AMMONIA PRODUCTION APPARATUS | THE UNIVERSITY OF TOKYO (JP) | 2023-09-21 | — | — | US | disclosed |
| CN-116693479-A | BysspinA derivative, preparation method and pharmaceutical application thereof | 中国医学科学院药物研究所 | 2023-09-05 | — | — | CN | disclosed |
| CN-111410659-B | PDE9 inhibitors and uses thereof | 药捷安康(南京)科技股份有限公司 | 2023-08-15 | — | — | CN | disclosed |
| US-5059515-A | STABILIZERS FOR COLOR PHOTOGRAPHIC RECORDING MATERIALS | CIBA-GEIGY AG (CH) | 1991-10-22 | — | — | US | disclosed |
| EP-0374095-A2 | Piperidine derivatives | CIBA-GEIGY AG (CH) | 1990-06-20 | — | — | EP | disclosed |
| EP-0359710-A1 | Optical brightening agents | CIBA-GEIGY AG (CH) | 1990-03-21 | — | — | EP | disclosed |
| EP-0309957-A1 | Stabilizers for colour-photographic recording materials | CIBA-GEIGY AG (CH) | 1989-04-05 | — | — | EP | disclosed |
| EP-0185079-B1 | N-SUBSTITUTED BUTYRAMIDE DERIVATIVES | CIBA-GEIGY AG (CH) | 1988-10-19 | — | — | EP | disclosed |
| EP-0225292-A2 | Certain N-substituted butyramide derivatives | CIBA-GEIGY AG (CH) | 1987-06-10 | — | — | EP | disclosed |
| EP-0185079-A1 | — | CIBA GEIGY AG | 1986-06-25 | — | — | EP | disclosed |
| WO-1986000066-A1 | N-SUBSTITUTED BUTYRAMIDE DERIVATIVES | CIBA-GEIGY AG (CH) | 1986-01-03 | — | — | WO | disclosed |
| US-4033977-A | ANTIINFLAMMATORY, ANTIDEPRESSANT | AMERICAN HOME PRODUCTS CORPORATION (US) | 1977-07-05 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20120220793-A1 | Method for Producing (Hydroxymethyl)Polysiloxanes | H1-2, RIOX2, RPS4Y1 | LMNA 1624/4885MEN1 1089/4885CYP3A4 1132/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.